学前儿童的喘药物:家长的知识,态度,做法和坚持
Jianlan Tang1, Zhihua Zhao1, Rong Guo1
1Department of Respiratory, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Engineering Research Center of Stem Cell Therapy, Chongqing, China.
Frontiers in pharmacology
|April 18, 2024
概括
患有喘的学龄前儿童的父母对药物治疗的知识和态度适度,但对药物治疗的良好做法. 然而,药物坚持率仍然很低,凸显了有针对性的教育干预措施的必要性.
科学领域:
- 儿科 儿科 儿科
- 呼吸系统医学 呼吸系统医学
- 健康 行为 健康行为
背景情况:
- 喘是一种在学龄前儿童中普遍存在的慢性呼吸道疾病.
- 父母的知识,态度和实践 (KAP) 对于有效的喘管理和药物坚持至关重要.
- 了解遵守的障碍对于制定有针对性的干预措施至关重要.
研究的目的:
- 分析家长对学龄前儿童喘药物的知识,态度和实践 (KAP).
- 为了评估这些儿童的药物服药程度.
- 为了确定影响药物坚持的因素.
主要方法:
- 这是一项涉及632名患有喘的学龄前儿童父母的横截面研究.
- 使用了评估KAP和人口特征的问卷.
- 使用莫里斯基药物坚持度表 (MMAS) 来衡量坚持.
主要成果:
- 父母表现出适度的知识 (63.27%) 和态度 (74.80%),但积极主动的做法 (91.53%) 关于喘药物.
- 发现药物坚持率很低 (平均得分为4.84/8).
- 积极态度得分 (OR=1.10),实践得分 (OR=1.16) 和父母吸烟 (OR=1.64) 与药物坚持有显著相关性.
结论:
- 学前喘儿童的父母表现出中度的KAP,但药物坚持度较低.
- 父母的态度,习惯和吸烟状况是影响遵守的关键因素.
- 建议进行持续的教育和培训计划,以加强喘药物管理和遵守.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Inhaled Medications
256
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
256
Asthma: Pathogenesis and Management
391
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
391
Antiasthma Drugs: β2-Adrenoceptor Agonists
256
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
256


